Oberweis Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28M Sell
289,485
-69,486
-19% -$7.13M 0.83% 39
2025
Q4
$38.1M Buy
358,971
+171
+0% +$19.8K 1.39% 8
2025
Q3
$45.6M Sell
358,800
-225
-0.1% -$26.8K 1.75% 7
2025
Q2
$44M Sell
359,025
-11,695
-3% -$1.34M 1.92% 5
2025
Q1
$37.5M Buy
370,720
+29,891
+9% +$2.92M 1.87% 4
2024
Q4
$31.5M Buy
340,829
+34,221
+11% +$3.36M 1.48% 6
2024
Q3
$29.6M Buy
306,608
+14,421
+5% +$1.3M 1.52% 4
2024
Q2
$25.1M Buy
292,187
+88,051
+43% +$7.39M 1.54% 7
2024
Q1
$16.9M Buy
204,136
+58,891
+41% +$4.31M 1.22% 10
2023
Q4
$9.69M Buy
145,245
+33,645
+30% +$2.18M 0.9% 19
2023
Q3
$7.5M Buy
111,600
+33,500
+43% +$2.3M 0.8% 23
2023
Q2
$5.29M Buy
+78,100
New +$4.89M 0.64% 39

Other funds holding EHC

Oberweis Asset Management's EHC Position: Q1 2026 in Review

Oberweis Asset Management reduced its Encompass Health (EHC) stake by 19% in Q1 2026, selling an estimated $7.13M and leaving 289,485 shares worth $28M. The position accounts for 0.83% of the portfolio, ranked #39.

Oberweis Asset Management first reported a position in EHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $45.6M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Oberweis Asset Management held 289,485 shares of Encompass Health worth $28M as of Q1 2026.
  • Oberweis Asset Management sold 69,486 Encompass Health shares in Q1 2026, an estimated $7.13M.
  • Encompass Health made up 0.83% of Oberweis Asset Management's portfolio in Q1 2026, its #39 holding.
  • Oberweis Asset Management first reported a position in Encompass Health in Q2 2023 and has held it in 12 quarters since.
  • Oberweis Asset Management's Encompass Health position peaked at $45.6M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.